Venture Capital Investors

Polymerase Capital

venture capital fund Polymerase Capital provides capital to promising tech companies.

Venture Investor Overview

Venture Investor
Polymerase Capital
Status
InActive
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Thomas Chalberg
Title
Founder
Mailing Address
119 South Main St 220
Seattle, WA 98104
USA
Phone
Undisclosed
Email Address

Background Information

Overview
Founded in 2021, Polymerase Capital is a venture capital firm. The firm seeks to invest in seed and early-stage life science companies.
Profile
Polymerase Capital LinkedIn Company Profile
Social Media
Polymerase Capital Company Twitter Account
Company News
Polymerase Capital News
Facebook
Polymerase Capital on Facebook
YouTube
Polymerase Capital on YouTube
Last Transaction
5/10/2022

Transaction History

Our records indicate that Polymerase Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
5/10/2022
$10,500,000

 


Investor Contacts

Title
Name
Email & Social
Founder
Thomas Chalberg
  Thomas Chalberg LinkedIn Profile  Thomas Chalberg Twitter Account  Thomas Chalberg News  Thomas Chalberg on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Polymerase Capital has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Polymatter Ventures | Polymorphic Capital

 

Share this article

 


About Our VC Firm Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary